Boc-Saxagliptin |
|
| Synonyms: N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-Carbamic Acid 1,1-Dimethylethyl Ester; | |
| Cat. No.: S12025 | CAS No.: 709031-43-6 |
| MDL.: | Formula: C23H33N3O4 |
| F.W.415.53 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | S12025 | CAS No.: | 709031-43-6 | |
| MDL: | Formula: | C23H33N3O4 | ||
| F.W.: | 415.53 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Application: | Boc-Saxagliptin is a Saxagliptin impurity, a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing. | |||
| Category: | Amines, Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals | |||








